Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
   FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
   
  
  April 30, 2024
  From CNBC.com News
 
   Walmart to shutter health centers, virtual care service in latest failed push into health care
   
  
  April 30, 2024
  From CNBC.com News
 
   Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
   
  
  April 30, 2024
  From CNBC.com News
 
   Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
   
  
  April 29, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
   
  
  April 25, 2024
  From CNBC.com News
 
   Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
   
  
  April 25, 2024
  From CNBC.com News
 
   Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
   
  
  April 25, 2024
  From CNBC.com News
 
   Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
   
  
  April 24, 2024
  From CNBC.com News
 
   Five things: Noncompete ban, biotech bankruptcy, outdoor dining and MassBio's big event
   
  
  April 24, 2024
  From Business Journals
 
   More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
   
  
  April 24, 2024
  From CNBC.com News
 
   Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
   
  
  April 24, 2024
  From CNBC.com News
 From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


